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Abstract
Background: The greater susceptibility of children to renal injury in post-diarrheal hemolytic-
uremic syndrome (HUS) may be related, at least in part, to heightened renal cell sensitivity to the
cytotoxic effect of Shiga toxin (Stx), the putative mediator of kidney damage in HUS. We
hypothesized that sexual maturation, which coincides with a falling incidence of HUS, may induce
a relatively Stx-resistant state in the renal cells.
Methods: Cultured human glomerular endothelial (HGEN), human glomerular visceral epithelial
(HGEC) and human proximal tubule (HPT) cells were exposed to Stx-1 after pre-incubation with
progesterone, β -estradiol or testosterone followed by determination of cytotoxicity.
Results: Under basal conditions, Stx-1 potently and dose-dependently killed HPT and HGEC, but
had relatively little effect on HGEN. Pre-incubation for 1, 2 or 7 days with physiologic or
pharmacologic concentrations of progesterone, β -estradiol or testosterone had no effect on Stx-
1 cytotoxicity dose-response on any cell type. In addition, no steroid altered Gb3 expression (Stx
receptor) by any cell type at any time point.
Conclusion:  These data do not support the notion that hormonal changes associated with
puberty induce an Stx-resistant state within kidney cells.
Background
The factors responsible for the age-related incidence of
post-diarrheal hemolytic uremic syndrome (HUS) are un-
known. Clinical data indicate that the peak incidence of
HUS occurs around two years of age, but the disease clear-
ly occurs in significant numbers of older children [1].
Population-based studies suggest that there is a decline in
the incidence of HUS from a peak at age 1–2 years until a
nadir at about age 11 years [1,2]. In addition, a case-con-
trol study of the Washington State outbreak of HUS re-
vealed that the mean age of patients with HUS was 8 years,
while the mean age of patients without HUS was 15 years
[3]. These studies raise the possibility, therefore, that the
appearance or disappearance of a factor or factors in ado-
lescents and adults reduces susceptibility to end-organ in-
jury in HUS.
HUS is thought to be due, at least in large part, to Shiga
toxin (Stx)-mediated cell toxicity [4]. Since the kidney is a
primary target of Stx in patients with HUS, it has been hy-
pothesized that the preferential renal injury occurring in
children with HUS is related to heightened renal suscepti-
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bility to Stx in this age group. Such increased renal sensi-
tivity to Stx in children, if it does indeed exist, could be
due to a wide variety of factors. One immediately appar-
ent factor that has been examined is age-related altera-
tions in renal Stx binding and Stx receptor (galactose-α -
1,4, galactose-β -1,4, glucose-ceramide (Gb3)) expression.
An autopsy study determined that total kidney Gb3 levels
were lower in infants than in adults (although only two
individuals under 19 years of age were examined) [5]. An-
other study using immunostaining of biopsy samples
found that glomeruli from infants (under two years of
age), but not from older children or adults, bound Stx [6].
This provocative finding, albeit involving a relatively
small sample size and patients who often had glomeru-
lopathies, provided a potential explanation for augment-
ed glomerular Stx sensitivity in young children.
Confirmation of these observations is needed, however
they do suggest that Gb3 levels, and in particular the pat-
tern of renal Gb3 expression, may be a factor in the age-
related incidence of renal injury in HUS.
The decreased incidence of HUS renal disease in adoles-
cents and adults raises the possibility that factors associat-
ed with puberty may be involved. There have been no
studies, to our knowledge, that have examined the effects
of puberty-related hormonal alterations on renal cell sen-
sitivity to Stx. Indeed, there is no information whatsoever
on how any sex steroid affects Stx responsiveness of any
cell type. It seemed reasonable, therefore, to examine
whether sex steroids (estrogen, progesterone and testo-
sterone) could modify the cytotoxic effect of Stx on renal
cells. Further, since Gb3 levels may be altered with aging,
the effect of sex steroids on renal cell Gb3 expression was
examined.
Several renal cell types have been demonstrated to re-
spond to Stx. Based on histologic evidence, glomerular en-
dothelial cells have been invoked as being primarily
involved in HUS renal injury [7]. In vitro studies have
demonstrated that human glomerular endothelial cells
(HGEN) bind Stx-1 and are modestly sensitive to the tox-
in's cytotoxic effect [8]. Recent work indicates that other
renal cell types may be Stx targets in HUS: cultured human
proximal tubule (HPT) [9] and human visceral glomeru-
lar epithelial (HGEC) [10] cells express abundant
amounts of Gb3 and are highly sensitive to the cytotoxic
effect of Stx-1. Consequently, the current study examined
the effect of sex steroids on Stx-1 cytotoxicity on, and Gb3
expression by, HGEN, HGEC and HPT.
Methods
Cell culture
Primary cultures of HPT were obtained from Clonetics
(San Diego, CA) and studied at the third passage. The
identity and purity of these cultures was established by
immunofluorescent staining as previously described [9]
(in addition to the extensive characterization by Clonet-
ics, we have determined that these cells lack von Wille-
brand factor and platelet endothelial cell adhesion
molecules (PECAM), but are positive for cytokeratin, im-
munofluorescence and alkaline phosphatase activity).
HPT were maintained in 1:1 Dulbecco's Modified Eagle
Media:Ham's F12 containing 25 mM HEPES, 2 mM L-
glutamine, 100 U/ml penicillin/streptomycin, 250 µg/L
amphotericin B, 1 µg/ml hydrocortisone, 10 µg/ml insu-
lin, 5.5 mg/ml transferrin, 6.7 µg/ml selenium, 0.2 gm/L
ethanolamine, 6.5 ng/ml L-thyroxine, 10 ng/ml epider-
mal growth factor, and 10% fetal bovine serum (FBS). Hy-
drocortisone was present in the media since HPT do not
grow well in the absence of corticosteroids (personal ob-
servation).
Primary cultures of HGEN were obtained from Cell Sys-
tems (Kirkland, WA) and studied at the third passage.
These cells have been extensively characterized by Cell
Systems; in addition, we determined that these cells have
von Willebrand factor and PECAM, but lack cytokeratin,
immunofluorescence. HGEN were maintained in EGM2-
MV media (Clonetics) which contains epidermal growth
factor, hydrocortisone, vascular endothelial cell growth
factor, basic fibroblast growth factor, insulin-like growth
factor-1, ascorbic acid, heparin and FBS.
Primary cultures of HGEC were obtained from nephrecto-
mies as previously described [10] and studied at the third
passage. Briefly, glomeruli were obtained by sieving renal
cortex, collagenase digested, and cultured in GEC media
(Media 199 + 20% FBS + 100 µg/ml Endothelial Growth
Supplement (PerImmune, Rockville, MD) + 100 U/ml
penicillin/streptomycin). Primary cultures were passaged
when 40% confluent and maintained in GEC media
thereafter. Cell identity and purity was determined as pre-
viously described [10]: all cells stained (by immunofluo-
rescence) negative for von Willebrand factor, PECAM and
anti-myosin, but were positive for cytokeratin.
Stx-1 cytotoxicity and Gb3 expression
Confluent cells in 96 well plates were placed in their
maintenance media without serum for 24 hr and exposed
to either high or low concentrations (see Results) of pro-
gesterone,  β -estradiol or testosterone (all from Sigma
Chemical Co., St. Louis, MO) for 1, 2 or 7 days in serum-
free media. Subsequently, Stx-1 (purified in our laborato-
ry [9]) was added for 72 hr at concentrations of 10-5 – 10-
11 grams/liter. The neutral red cytotoxicity assay was per-
formed [9]. Briefly, 50 µg/ml neutral red in Media 199
containing 5% serum was added for 2–3 hours at 37°C.
Cells were washed with 1% CaCl2 + 1% formaldehyde
and solubilized in 1% acetic acid in 50% ethanol. Absorp-
tion was read at 450 nm.BMC Nephrology 2002, 3 http://www.biomedcentral.com/1471-2369/3/6
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For determination of Gb3 content, cells grown in 6-well
plates were placed in serum-free media for 24 hr followed
by addition of the steroids for 1, 2 or 7 days. Gb3 was
quantitated as previously described [9]. Briefly, cells were
scraped off the plates, centrifuged, the pellet extracted in
chloroform:methanol:water and separated on high per-
formance thin layer chromatography-silica plates
(Mallinckrodt Baker Inc., Paris, KY) by ascending chroma-
tography. The plates were dried, immersed in 0.5%
polyisobutylmethacrylate in acetone, and sequentially in-
cubated with Stx-1, anti-Stx-1 monoclonal antibody (pu-
rified from a hybridoma cell line, 13C4 (ATCC, Rockville,
MD), as previously described [9]), and 125I-goat anti-
mouse IgG (DuPont NEN, Boston, MA). Gb3 concentra-
tions were calculated by densitometry (Eagle Eye II, Strat-
agene, LaJolla, CA) and standardized to total protein.
Prior to centrifugation, a cell aliquot was solubilized in
0.1 N NaOH, mixed with Bradford reagent (Bio-Rad,
Richmond, CA) and protein concentration determined by
measuring absorbance at 590 nm.
Statistics
All data were analyzed by one way analysis of variance. In-
dividual conditions were compared using Student's t-test
after the Bonferroni correction. P values < 0.05 were taken
as significant.
Results
Stx-1 (72 hr exposure to toxin) dose-dependently killed
HGEN, HGEC and HPT (Figure 1). In HGEN, Stx-1 had an
LD50 of about 10-5 g/L (140 pM), while in HGEC the
LD50 for Stx- was about 10-8 g/L (140 fM) and in HPT the
LD50 for Stx was about 10-9.5 g/L (4.4 fM).
Exposure for 1, 2 or 7 days to high (1 µM) or physiologic
concentrations (reference range of physiologic steroid
concentrations based on Barnes Hospital Laboratory
Manual [11]) of progesterone (30 nM), β -estradiol (100
pM), or testosterone (30 nM) had no effect on HGEN (Ta-
ble 1), HGEC (Table 2) or HPT (Table 3) responsiveness
to Stx-1. For the sake of brevity, the tables illustrate the ef-
fect of 10-5, 10-8, and 10-11 g/L Stx-1, however a full dose-
response from 10-5 – 10-11 g/L Stx-1, in ten-fold concen-
tration increments, was done for each condition: there
was also no significant effect of these other concentrations
of sex steroids on the cytotoxic effects of Stx-1 on any of
the renal cell types. In addition, physiologic or pharmaco-
logic concentrations of progesterone, estradiol or testo-
sterone had no effect on baseline (without exposure to
Stx-1) HGEN, HGEC or HPT survival.
The effect of 1, 2 or 7 days of exposure to physiologic or
pharmacologic concentrations of progesterone, estradiol
or testosterone on Gb3 expression by HGEN, HGEC or
HPT was also examined. A representative blot of Gb3 con-
tent is shown in Figure 2 (figure illustrates 2 day steroid
exposure in HPT) to demonstrate that Gb3 isolated from
cells migrated on the gel at the same position as purified
Gb3. As for Stx-cytotoxicity, none of the steroids, at any
dose or exposure time, modified Gb3 content in any cell
type (n = 3 each condition, data not shown).
Immunoreactive steroid concentration was determined in
media samples at the start and conclusion of the 7 day ex-
periment (analyzed in clinical laboratory at Associated Re-
gional University Pathologists, Salt Lake City, UT) in
order to determine the stability of the added steroids. Es-
tradiol and testosterone concentrations did not vary over
1, 2 or 7 days in culture media. Progesterone levels also
did not fall after 1–2 days in culture media, however after
7 days in media the progesterone concentration signifi-
cantly dropped (80% decrease). Consequently, fresh pro-
gesterone was added to the 7 day experiments every two
days.
The failure of steroids to affect Stx cytotoxicity was not due
to inactivity of the steroid preparations. Similar prepara-
tions and concentrations of steroids from the same suppli-
er (Sigma) were tested by Dr. Wayne Meikle in the
Division of Endocrinology at the University of Utah using
an in-house estrogen and progesterone binding assay and
a testosterone-dependent stimulation of prostate cancer
cell apoptosis assay [12]; all the steroids retained biologic
activity (data not shown).
Discussion and Conclusion
The reasons why HUS primarily affects children are un-
known. It is evident that the peak incidence of HUS occurs
in very young children (1–2 years of age). The factors re-
sponsible for this apparent heightened sensitivity to infec-
tion with Stx-expressing bacteria have not been
extensively investigated and were not examined in the cur-
rent study. Indeed, it is conceivable that not all of the fac-
tors involved in HUS occurrence in young children are
identical to those involved in the diminished HUS inci-
dence in adolescents and adults. Numerous factors could
be involved in age-related Stx sensitivity, including differ-
ences in the degree of enteric invasion by Stx-producing E.
coli; in Stx transport across the gut, in circulating red or
white blood cell toxin binding and delivery to the kidney,
in the immune response to Stx, in renal Stx binding, and/
or in intrinsic or cofactor-regulated (e.g. inflammatory cy-
tokines) renal Stx responsiveness. The current study eval-
uated one of these possibilities, namely that renal cell Stx-
1 responsiveness decreases with age due, at least partially,
to hormonal changes associated with puberty. As stated
earlier, there is no precedent in the literature for examina-
tion of the effect of sex steroids on Stx responsiveness,
however, the coincidental fall in clinically apparent HUS
in adolescents and adults [1] raises the possibility thatBMC Nephrology 2002, 3 http://www.biomedcentral.com/1471-2369/3/6
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hormonal changes associated with puberty induce a rela-
tively Stx-resistant state in the kidney.
HGEN, HGEC and HPT were chosen for examination in
this study because these cell types, at least in vitro, have
been shown to be injured by Stx-1 [6–8]. Mesangial cells
were not examined since Stx-1 has not been demonstrated
to affect their viability [13]. Previous studies have sepa-
rately examined the cytotoxic effect of Stx-1 on HGEN [8],
HGEC [10], and HPT [9], however this is the first study to
directly compare Stx-1 sensitivity of these renal cell types.
These data indicate that, as suggested from the previous
studies, within the limits of the cell culture system, HPT
are the most sensitive to Stx-1 cytotoxicity of the three cell
types, HGEC are slightly less sensitive, and HGEN are at
least three orders of magnitude less sensitive than either
Figure 1
Effect of Stx-1 (72 hr exposure) on cell survival in cultured human glomerular endothelial cells (HGEN), human glomerular epi-
thelial cells (HGEC) or human proximal tubule cells (HPT). N = 9 for each data point. % control refers to control cells not
exposed to toxin.
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Table 1: Effect of sex steroids on Stx-1 cytotoxicity in human glomerular endothelial cells (HGEN). Cells were exposed to high and low 
concentrations of steroids for 1, 2 or 7 days followed by addition of varying concentration of Stx-1 for 72 hr. Cell survival was determined 
at the end of the experiment. % survival refers to percent of cells surviving after exposure to Stx-1 ± steroids. N = 9 each data point. 
Results are expressed as mean ± SEM.
HGEN Dose [Stx-1] gm/L Stx alone (% survival) Day 1 (% survival) Day 2 (% survival) Day 7 (% survival)
Estradiol 1 µM- 5 5 4   ± 44 9  ± 3 49 ± 6 48 ± 6
1 µM- 8 9 0   ± 78 6  ± 6 85 ± 8 95 ± 6
1 µM -11 102 ± 81 0 2  ± 10 105 ± 4 91 ± 8
100 pM -5 54 ± 45 1  ± 3 55 ± 3 58 ± 4
100 pM -8 90 ± 78 7  ± 6 96 ± 9 85 ± 9
100 pM -11 102 ± 89 6  ± 6 103 ± 11 115 ± 11
Progesterone 1 µM- 5 5 4   ± 45 1  ± 4 50 ± 4 45 ± 6
1 µM- 8 9 0   ± 78 4  ± 9 85 ± 8 95 ± 7
1 µM -11 102 ± 81 0 0  ± 4 103 ± 6 95 ± 7
30 nM -5 54 ± 45 3  ± 3 53 ± 4 52 ± 5
30 nM -8 90 ± 79 1  ± 9 92 ± 7 94 ± 9
30 nM -11 102 ± 81 0 2  ± 7 104 ± 7 100 ± 7
Testosterone 1 µM- 5 5 4   ± 45 8  ± 5 55 ± 2 56 ± 3
1 µM- 8 9 0   ± 79 1  ± 8 92 ± 9 94 ± 10
1 µM -11 102 ± 81 0 3  ± 12 95 ± 8 102 ± 7
30 nM -5 54 ± 45 2  ± 4 54 ± 4 55 ± 3
30 nM -8 90 ± 78 6  ± 6 90 ± 6 94 ± 8
30 nM -11 102 ± 89 6  ± 6 100 ± 5 104 ± 8
Table 2: Effect of sex steroids on Stx-1 cytotoxicity in human glomerular epithelial cells (HGEC). Cells were exposed to high and low 
concentrations of steroids for 1, 2 or 7 days followed by addition of varying concentration of Stx-1 for 72 hr. Cell survival was determined 
at the end of the experiment. % survival refers to percent of cells surviving after exposure to Stx-1 ± steroids. N = 9 each data point. 
Results are expressed as mean ± SEM.
HGEC Dose [Stx-1] gm/L Stx alone (% survival) Day 1 (% survival) Day 2 (% survival) Day 7 (% survival)
Estradiol 1 µM -5 54 ± 4 51 ± 4 51 ± 3 48 ± 5
1 µM -8 90 ± 7 79 ± 10 94 ± 8 86 ± 5
1 µM -11 102 ± 8 96 ± 10 107 ± 5 95 ± 8
100 pM -5 54 ± 4 53 ± 4 52 ± 3 50 ± 4
100 pM -8 90 ± 7 88 ± 8 89 ± 6 83 ± 7
100 pM -11 102 ± 8 106 ± 7 96 ± 9 98 ± 9
Progesterone 1 µM -5 54 ± 4 54 ± 49 56 ± 5 54 ± 2
1 µM -8 90 ± 7 83 ± 9 90 ± 9 90 ± 5
1 µM -11 102 ± 8 101 ± 3 101 ± 6 103 ± 7
30 nM -5 54 ± 4 50 ± 6 58 ± 4 50 ± 5
30 nM -8 90 ± 7 86 ± 4 92 ± 6 78 ± 9
30 nM -11 102 ± 8 97 ± 7 105 ± 7 93 ± 7
Testosterone 1 µM -5 54 ± 4 53 ± 4 55 ± 4 50 ± 4
1 µM -8 90 ± 7 90 ± 11 90 ± 7 84 ± 6
1 µM -11 102 ± 8 103 ± 9 100 ± 7 105 ± 5
30 nM -5 54 ± 4 59 ± 6 59 ± 4 54 ± 9
30 nM -8 90 ± 7 84 ± 8 89 ± 5 82 ± 7
30 nM -11 102 ± 8 98 ± 6 106 ± 8 97 ± 6BMC Nephrology 2002, 3 http://www.biomedcentral.com/1471-2369/3/6
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HGEC or HPT. Such differential sensitivity is quite inter-
esting, particularly considering that glomerular endotheli-
al cell damage is a prominent histologic feature in
biopsies obtained from patients with clinically well estab-
lished HUS [7]. The significance of these observations re-
mains, therefore, to be determined. Although speculative,
it is tempting to propose that HPT and HGEC may be early
targets of Stx-1 and that this could play a role in the patho-
physiologic processes that characterize renal injury in
HUS.
Estrogen, progesterone or testosterone did not affect Stx-1
mediated renal cell cytotoxicity or Gb3 expression. Cells
were exposed to the steroids for up to one week in order
to allow time for steroid-regulated gene transcription and
protein expression. In addition, both physiologic and
pharmacologic concentrations of steroids were utilized.
Despite these efforts to be insure that the system was op-
timized in order to detect a steroid-mediated alteration of
Stx responsiveness, the concern still exists that this system
may not really reflect the influences of sex steroids in vivo.
Indeed, one might argue that an animal model, in which
the testes or ovaries are removed and the animals are giv-
en Stx in the presence and absence of steroid replacement,
would be better. Such studies would, however, be prob-
lematic. Traditional animal models, such as mice, rats,
rabbits or pigs do not develop typical renal disease when
given either Stx or E. coli 0157:H7 [14]. Further, animal
models that most closely reflect human HUS are only in
the early stages of development [14]. Hence, the cell cul-
ture system remains the most reasonable means to assess
an effect of sex steroids on renal cell Stx-1 responsiveness;
such systems have clearly been demonstrated to be re-
sponsive to sex steroids (e.g. testosterone-regulated KAP
promoter activity in proximal tubule cells [15] as well as
estrogen-regulated endothelial cell function [16]). Given
these limitations, our data suggest that sex steroids do not
alter renal cell sensitivity to the cytotoxic effects of this Stx-
1. Consequently, the reasons why clinically apparent HUS
primarily occurs in children remains to be determined.
List of Abbreviations
HUS hemolytic-uremic syndrome
Table 3: Effect of sex steroids on Stx-1 cytotoxicity in human proximal tubule cells (HPT). Cells were exposed to high and low concen-
trations of steroids for 1, 2 or 7 days followed by addition of varying concentration of Stx-1 for 72 hr. Cell survival was determined at 
the end of the experiment. % survival refers to percent of cells surviving after exposure to Stx-1 ± steroids. N = 9 each data point. Results 
are expressed as mean ± SEM.
HPT Dose [Stx-1] gm/L Stx alone (% survival) Day 1 (% survival) Day 2 (% survival) Day 7 (% survival)
Estradiol 1 µM -5 54 ± 44 9  ± 45 0  ± 4 46 ± 5
1 µM -8 90 ± 78 1  ± 78 3  ± 7 84 ± 9
1 µM -11 102 ± 89 7  ± 59 9  ± 7 107 ± 7
100 pM -5 54 ± 44 9  ± 46 0  ± 4 49 ± 6
100 pM -8 90 ± 79 5  ± 89 0  ± 7 87 ± 8
100 pM -11 102 ± 89 7  ± 6 103 ± 5 92 ± 9
Progesterone 1 µM -5 54 ± 45 6  ± 45 2  ± 3 60 ± 5
1 µM -8 90 ± 79 9  ± 98 1  ± 7 91 ± 9
1 µM -11 102 ± 8 107 ± 8 101 ± 5 106 ± 8
30 nM -5 54 ± 45 0  ± 65 2  ± 3 54 ± 4
30 nM -8 90 ± 78 6  ± 48 3  ± 5 90 ± 5
30 nM -11 102 ± 89 7  ± 7 105 ± 5 92 ± 7
Testosterone 1 µM -5 54 ± 45 7  ± 34 9  ± 4 58 ± 5
1 µM -8 90 ± 79 2  ± 78 9  ± 5 91 ± 8
1 µM -11 102 ± 89 4  ± 59 7  ± 6 100 ± 6
30 nM -5 54 ± 45 1  ± 46 4  ± 7 57 ± 3
30 nM -8 90 ± 79 8  ± 89 7  ± 7 85 ± 5
30 nM -11 102 ± 8 109 ± 10 102 ± 6 103 ± 7
Figure 2
Representative blot of Gb3 expression by human proximal
tubule cells after 48 hr exposure to media alone (control), 1
µM β -estradiol, 1 µM progesterone or 1 µM testosterone. A
Gb3 standard is shown for reference. Identical results were
obtained at 1 and 7 days of steroid exposure.
 Gb3   Control            Estradiol        Testosterone    ProgesteroneBMC Nephrology 2002, 3 http://www.biomedcentral.com/1471-2369/3/6
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HGEN human glomerular endothelial cells
HGEC human glomerular visceral epithelial cells
HPT human proximal tubule cells
Stx-1 Shiga toxin-1
Gb3 galactose-α -1,4, galactose-β -1,4, glucose-ceramide
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